Earnings season week five preview

The profit season may come to an end this week, but there is still enough for investors to pay attention to.

Here is an example of week five:


This morning, the results are expected to be released from the telco company Amaysim Australia Ltd (ASX: AYS), struggling childcare operator G8 Education Ltd (ASX: GEM), fertility treatment company Monash IVF Group Ltd (ASX: MVF) and manufacturer of broadband equipment Netcomm Wireless Ltd (ASX: NTC).

I will look forward to improvements in the ARPU of Amaysim, the occupancy levels of G8 Education and the trading conditions for Monash IVF. The market undoubtedly expects a strong result from Netcomm Wireless after it has achieved an impressive half-year result, with sales up 89% to $ 88.6 million.


Three big results will be released on Tuesday by the fast-growing tech star Appen Ltd (ASX: APX), company for dietary supplements Blackmores Limited (ASX: BKL) and fuel seller Caltex Australia Limited (ASX: CTX). According to Bloomberg's consensus estimate, the market is looking for NPAT of 70.7 million from Blackmores in FY 2018.

Elsewhere I think there is a fairly strong chance that Appen will upgrade its annual guidance when it publishes its half-year results. I expect this to be driven by the strong demand from the machine learning market and favorable currency movements.


The Wednesday is expected to be a busy day with releases scheduled for the game technology company Ainsworth Game Technology Limited (ASX: AGI), infant formula Bellamy & # 39; s Australia Ltd (ASX: BAL), building materials company Boral Limited (ASX: BLD), company for personal care products BWX Ltd (ASX: BWX), telecom and cloud service company Macquarie Telecom Group Ltd (ASX: MAQ), company for regenerative medicine Sirtex Medical Limited (ASX: SRX) and airline Virgin Australia Holdings Ltd (ASX: VAH).

According to Bloomberg's consensus estimate, the NPAT market expects $ 45.7 million from Bellamy's. However, all eyes are focused on guidance and an update of the CFDA application.


It looks like Thursday is a quieter day with only three scheduled releases. These include struggling private hospital operator Ramsay Health Care Limited (ASX: RHC), casino operator Donaco International Ltd (ASX: DNA) and financial services provider Perpetual Limited (ASX: PPT).

With respect to the Ramsay result, investors will focus on the outlook for the coming year and whether trading conditions have improved.


The week ends with results from the company of plumbing parts Reece Ltd (ASX: REH) and data center operator NEXTDC Ltd (ASX: NXT). The latter is not expected to yield a strong profit result due to increased investments in its data centers to feed future growth. But investors expect the company to report a strong increase in demand for its data center services to support its significant capacity increase.

Not sure which stocks to collect? View these market beaters.

Top 3 ASX Blue Chips for sale in 2018

For many, blue chip & # 39; shares mean stability, profitability and regular dividends, often fully franked.

But knowing which blue chips you have to buy and when can be full of dangers.

The internal analyst team of the Motley Fool has spent thousands of hours on its own research to give you the names of "The Motley Fool & # 39; s Top 3 Blue Chip Stocks for 2018."

Everyone pays a fully finalized dividend. They have not only grown their profits, but also increased their dividend. One increased it by as much as 33%, while another acted on a total (fully fringe) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included specially prepared free report. But you will have to hurry. Depending on the demand – and how quickly the stock prices of these companies are evolving – we can be forced to delete this report.

click here to claim your free report.

Motley Fool employee James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia owns shares and has recommended Blackmores Limited and BWX Limited. The Motley Fool Australia owns Appen Ltd shares. The Motley Fool Australia has recommended Monash IVF Group Ltd and Ramsay Health Care Limited. We Fools may not all have the same opinion, but we are all convinced that considering a wide range of insights makes us better investors. The Motley Fool has a disclosure policy. This article only contains general investment advice (under AFSL 400691). Authorized by Scott Phillips.

Source link

Leave a Reply